Carticept Medical completes $20M Series B financing round Carticept Medical, Inc., a developer of innovative products for the treating cartilage accidents and osteoarthritis, today announced that it provides completed a $20 million Series B financing round. New investor SonoSite, Inc. Joined existing investors Domain New and Associates Business Associates. Patrick, Chief and President Executive Officer.”.Pulmonary function research or pulmonary function checks may be helpful in assessing the type and just how much lung harm has occurred. Bronchiectasis is definitely a form of chronic obstructive pulmonary disease , which testing can help confirm this. These assessments can help determine if the lung cells will respond to the usage of bronchodilator treatment with inhaler medications . Repeated as time passes, pulmonary function studies might help document the advantages of progression or treatment of the disease. Less commonly, bronchoscopy is used to look inside the airways with a fiberoptic camera. That is sometimes done to look for tumors or international bodies that may have been noticed on CT.